| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |